REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company. Mr. Baldino, who will also serve as […]
Dr. John Thoppil, Current President of the Texas Association of Obstetricians and Gynecologists (TAOG), Performs Sonata Procedure in Austin Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Dr. John Thoppil is the first physician in the […]
Redwood City, CA, September 29, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Robert Brown has joined the company as Chief Financial Officer, starting immediately. Mr. Brown’s background includes significant experience successfully scaling business in healthcare, including medical devices. He most […]
The Only Transcervical, Incisionless System for Radiofrequency Ablation of Fibroids Provides New Benefits through Features Such as Increased Range of Ablation Sizes, a New User Interface, and Validation of Additional Low Temperature Hospital Reprocessing Systems Redwood City, CA, September 16, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions […]
Anthem’s decision significantly increases nationwide access for Sonata Redwood City, CA, September 14, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced Anthem, Inc., the largest managed health care company in the Blue Cross Blue Shield Association, has provided positive payer coverage for the […]
The Combined Clinical Experience of Over 1000 Sonata Procedures, Across Three Countries, Drives New Recommendation for Sonata as a First Line Therapy for Fibroid Treatment Redwood City, CA, August 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today a group of 12 […]
Florida Blue is the Largest Healthcare Payer in that State Redwood City, CA, June 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today Blue Cross Blue Shield of Florida (Florida Blue) has released a coverage policy for its Sonata® Procedure.1 The addition […]
Current President and Head of Siemens Healthineers in The Americas Brings Strong Commercial Experience to the Board of Directors Karen Talmadge, Ph.D., Remains as Independent Board Member, Retaining Key Strengths and Experience for Gynesonics Redwood City, CA, June 7, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for […]
The national policy covers approximately 15 million lives in 48 states and Washington D.C. for this minimally invasive, uterine-preserving and incision-free treatment Redwood City, CA, June 3, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Cigna has released a national coverage […]
Additionally, an expert physician panel in Europe reached consensus and published a new recommended fibroid treatment algorithm with transcervical radiofrequency ablation (Sonata) at the forefront Redwood City, CA, June 1, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of guidelines by […]